Appili Therapeutics Raises $10.3M

Appili Therapeutics Inc., the Halifax company dedicated to fighting infectious diseases, has raised $10.25 million by selling shares and warrants to mainly institutional investors.
The fundraising round – the company’s first since it listed on the TSX Venture exchange in June – comes after the company has undergone a series of changes in senior executives and its board. The company will use the